Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation (2013)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FMRP
- DOI: 10.1089/cbr.2012.1415
- Subjects: RADIOTERAPIA; MITOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Biotherapy and Radiopharmaceuticals
- ISSN: 1084-9785
- Volume/Número/Paginação/Ano: v. 28, n. 7, p. 516-522, 2013
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
PEZUK, Julia Alejandra et al. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, v. 28, n. 7, p. 516-522, 2013Tradução . . Disponível em: https://doi.org/10.1089/cbr.2012.1415. Acesso em: 02 abr. 2026. -
APA
Pezuk, J. A., Brassesco, M. S., Morales, A. G., Oliveira, J. C. de, Oliveira, H. F. de, Scrideli, C. A., & Tone, L. G. (2013). Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, 28( 7), 516-522. doi:10.1089/cbr.2012.1415 -
NLM
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1089/cbr.2012.1415 -
Vancouver
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1089/cbr.2012.1415 - Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro
- Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells
- Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia
- BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity
- Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells
- PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
